References
- EntineJFDA balances costs, patient safety in the biologics and per-sonalized medicine revolutionForbes2012 Available from: https://www.forbes.com/sites/jonentine/2012/07/23/fda-balances-costs-patient-safety-in-the-biologics-and-personalized-medicine-revolution-will-it-get-it-right-or-damage-the-miracle-industry/#9b1a87a1d366Accessed September 23, 2018
- DimasiJAGrabowskiHGHansenRWInnovation in the pharmaceutical industry: New estimates of R&D costsJ Health Econ201647203326928437
- Hospira.com [homepage on the Internet]Lake Forest, ILHospira Available from: https://www.hospira.com.au/en/about_hospira/biologics/developing_biosimilarsAccessed May 16, 2018
- investor.regeneron.com [homepage on the Internet]Eastview, MNRegeneron Available from: http://investor.regeneron.com/releasedetail.cfm?releaseid=1047691Accessed May 16, 2018
- gminsights.com [homepage on the Internet]Ocean View, DEGlobal Market Insights Available from: https://www.gminsights.com/industry-analysis/diabetic-retinopathy-market-reportAccessed May 16, 2018
- prnewswire.com [homepage on the Internet]New York, NYPR Newswire Available from: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-marketAccessed May 16, 2018
- fdagov [homepage on the Internet]Silver Spring MDUS Food and Drug Administration Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/ucm580429.htmAccessed September 23, 2018
- BlankTTilonetzerWHVogt-EiseleAKaszkin-BettagMSafety and toxicity of biosimilars – EU versus US regulationGaBI J201323144150
- gabionline.net [homepage on the Internet]Mol, BelgiumGenerics and Biosimilars Initiative Available from: http://www.gabionline.net/Guidelines/Global-guidelines-for-biosimilarsAccessed May 16, 2018
- SharmaSKhanMAChaturvediARE-ENACT Study Investigators GroupReal Life Clinical Effectiveness of Razumab® (World’s First BiosimilarRanibizumab) in Wet Age-Related Macular Degeneration: A Subgroup Analysis of Pooled Retrospective RE-ENACT StudyInt J Ophthalmol Eye201862368373
- SharmaSKhanMAChaturvediARE-ENACT Study Investigators GroupReal Life Clinical Effectiveness of Razumab® (World’s First BiosimilarRanibizumab) in Retinal Vein Occlusion: A Subgroup Analysis of Pooled Retrospective RE-ENACT StudyOphthalmologica201818 Epub2018626
- medscape.com [homepage on the Internet]New York, NYMedscape Available from: https://www.medscape.com/viewarticle/867481Accessed May 16, 2018
- indianexpress.com [homepage on the Internet]New DelhiThe Indian Express Available from: http://indianexpress.com/article/business/companies/undertaking-detailed-analysis-patients-report-eye-inflammation-intas-recalls-its-drug-batch-4596914/Accessed May 16, 2018
- BankerAA new biosimilar ranibizumab for retinal diseasesPaper presented at: American Society of Retina Specialists Annual MeetingAugust 9–14 2016San Francisco, CA.
- formycon.com [homepage on the Internet]Martinsried, GermanyFormycon Available from: http://www.formycon.com/en/press-release/formycon-and-bioeq-achieve-important-milestone-biosimilar-ranibi-zumab-candidate-fyb201-shows-efficacy-comparable-to-the-reference-product-in-phase-iii-study/Accessed May 16, 2018
- biosimilarnews.com [homepage on the Internet] Available from: http://www.biosimilarnews.com/2017/02/xbrane-biopharma-reports-positive-in-vitro-biosimilarity-data-on-ranibizumab-biosimilar/Accessed May 16, 2018
- ois.net [homepage on the Internet]Raleigh, NCOIS Available from: https://ois.net/pfenex-moves-forward-with-lucentis-biosimilar/Accessed May 16, 2018
- coherus.com [homepage on the Internet]Redwood City, CACoherus BioSciences Available from: https://www.coherus.com/our-products/Accessed May 16, 2018
- clinicaltrialsgov [homepage on the Internet]Bethesda, MAUS National Library of medicine Available from: https://clinicaltrials.gov/ct2/show/NCT03150589?cond=SB11&rank=1Accessed May 16, 2018
- gabionline.net [homepage on the Internet]Mol, BelgiumGenerics and Biosimilars Initiative Available from: http://www.gabionline.net/Biosimilars/General/Mylan-Momenta-announce-development-strategy-for-aflibercept-biosimilarAccessed May 16, 2018
- centerforbiosimilars.com [homepage on the Internet] Available from: http://www.centerforbiosimilars.com/news/eye-on-pharma-alteogen-to-file-ind-for-proposed-aflibercept-biosimilarAccessed May 16, 2018
- bioeq.com [homepage on the Internet]Germanybioeq Available from: http://www.bioeq.com/development-programs/fyb203/Accessed May 16, 2018
- adisinsight.springer.com [homepage on the Internet]Fremont, CAAdisInsight Available from: https://adisinsight.springer.com/drugs/800051416Accessed May 16, 2018
- gabionline.net [homepage on the Internet]Mol, BelgiumGenerics and Biosimilars Initiative Available from: http://gabionline.net/Biosimilars/General/Biosimilars-of-bevacizumabAccessed May 16, 2018
- MulcahyAPredmoreZMattkeSThe cost savings potential of bio-similar drugs in the United StatesSanta Monica, CARand Corporation2014 Available from: https://www.rand.org/content/dam/rand/pubs/perspectives/PE100/PE127/RAND_PE127.pdfAccessed May 16, 2018
- raps.org [homepage on the Internet]Washington, DCRaps Available from: https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2016/1/india%E2%80%99s-cdsco-warns-against-using-roche%E2%80%99s-avastin-as-eye-treatment\Accessed May 16, 2018
- clinicaltrials.gov [homepage on the Internet]Bethesda, MAUS National Library of medicine Available from: https://clinicaltrials.gov/ct2/show/NCT02510794Accessed May 16, 2018